deltatrials
Terminated PHASE3 NCT00315900

Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia

Depakote ER vs. Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia

Sponsor: Abbott

Conditions Agitation Dementia
Interventions Depakote ER Seroquel
Updated 6 times since 2017 Last updated: Apr 25, 2017 Started: May 1, 2006 Primary completion: Dec 1, 2007 Completion: Feb 28, 2008

This PHASE3 trial investigates Agitation and Dementia and is currently terminated or withdrawn. Abbott leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. May 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    Status: Completed → Terminated

▶ Show 1 earlier version

  1. Jan 2017 — May 2017 [monthly]

    Completed PHASE3

    First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott
  • Tuscaloosa Research & Education Advancement Corporation
Data source: Tuscaloosa Research & Education Advancement Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tuscaloosa, United States